The Trump administration has selected 10 companies, including AbbVie (ABBV), Amgen (AMGN), Pfizer (PFE), and GSK (GSK), for a new pilot program that tests a rebate model for drugs purchased under a federal
The Trump administration has selected 10 companies, including AbbVie (ABBV), Amgen (AMGN), Pfizer (PFE), and GSK (GSK), for a new pilot program that tests a rebate model for drugs purchased under a federal
